Raffaele Ratta

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Prostate Cancer

Radiation Therapy

Top Venues

Prostate cancer and prostatic diseases

Future oncology (London, England)

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Elodie Dang, Alexandre Vallée, Coralie Lepage-Seydoux, Karine Sejean, Brigitte Bonan, Christine Abraham, Philippe Beuzeboc, Raffaele Ratta
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study. Current oncology (Toronto, Ont.) 29 (2) (2022)
Daniel P Petrylak, Raffaele Ratta, Rustem Airatovich Gafanov, Gaetano Facchini, Josep Maria Piulats, Gero Kramer, Thomas W Flaig, Sreenivasa R Chandana, Ben Li, Joseph Burgents, Karim Fizazi
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer. Future oncology (London, England) 17 (25) (2021)
Raffaele Ratta, Annalisa Guida, Florian Scotté, Yann Neuzillet, Asmahane Benmaziane Teillet, Thierry Lebret, Philippe Beuzeboc
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review. Prostate cancer and prostatic diseases 23 (4) (2020)